Document Preview Unavailable

Intravenous Hydroxypropyl β‐Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single‐Ascending, and Multiple‐Dose Trial

K Erb‐Zohar; Kropeit, D; Scheuenpflug, J; H‐P Stobernack; Hulskotte, EGJ; et al.  Clinical and Translational Science Vol. 10, Iss. 6,  (Nov 2017): 487-495.

You might have access to this document